Bank of New York Mellon’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Buy |
307,853
+59,473
| +24% | +$387K | ﹤0.01% | 2739 |
|
|
2025
Q1 | $1.97M | Buy |
248,380
+3,551
| +1% | +$28.2K | ﹤0.01% | 2688 |
|
|
2024
Q4 | $3.1M | Buy |
244,829
+74,091
| +43% | +$939K | ﹤0.01% | 2529 |
|
|
2024
Q3 | $2.38M | Sell |
170,738
-37,658
| -18% | -$525K | ﹤0.01% | 2665 |
|
|
2024
Q2 | $2.87M | Sell |
208,396
-6,987
| -3% | -$96.3K | ﹤0.01% | 2597 |
|
|
2024
Q1 | $3.56M | Sell |
215,383
-18,815
| -8% | -$311K | ﹤0.01% | 2485 |
|
|
2023
Q4 | $3.42M | Buy |
234,198
+13,902
| +6% | +$203K | ﹤0.01% | 2562 |
|
|
2023
Q3 | $2.7M | Buy |
220,296
+40,387
| +22% | +$496K | ﹤0.01% | 2639 |
|
|
2023
Q2 | $2.15M | Buy |
179,909
+68,278
| +61% | +$815K | ﹤0.01% | 2792 |
|
|
2023
Q1 | $1.49M | Buy |
111,631
+11,130
| +11% | +$149K | ﹤0.01% | 2952 |
|
|
2022
Q4 | $2.16M | Sell |
100,501
-1,722
| -2% | -$37.1K | ﹤0.01% | 2820 |
|
|
2022
Q3 | $2.05M | Buy |
102,223
+38,681
| +61% | +$775K | ﹤0.01% | 2836 |
|
|
2022
Q2 | $1.14M | Buy |
63,542
+6,052
| +11% | +$108K | ﹤0.01% | 3153 |
|
|
2022
Q1 | $570K | Buy |
57,490
+25,250
| +78% | +$250K | ﹤0.01% | 3631 |
|
|
2021
Q4 | $543K | Buy |
32,240
+5,445
| +20% | +$91.7K | ﹤0.01% | 3756 |
|
|
2021
Q3 | $635K | Buy |
+26,795
| New | +$635K | ﹤0.01% | 3660 |
|